Skip to Main Content

Paper Details

Healthcare Utilization and Costs after Receiving a Positive <i>BRCA1/2</i> Result from a Genomic Screening Program.
J Pers Med
14
2020
(, BRCA1/2, BRCA1/2 P/LP variant, BRCA1/2 variant, Cancer, breast or ovarian cancer, participants, patients, women
Author NameAffiliation
Kandamurugu ManickamNationwide Children's Hospital
Michael F MurrayYale School of Medicine
Michael F MurrayYale School of Medicine
Alanna Kulchak RahmGenomic Medicine Institute
Marc S WilliamsGenomic Medicine Institute
Adam H BuchananGenomic Medicine Institute
Amy C SturmGenomic Medicine Institute
  • 1 - 7

Datasets

Release 1.2